Clinical trial

Real World Use of Tocilizumab Biosimilar studY

NCT06247722

StatusACTIVE_NOT_RECRUITING

Study typeOBSERVATIONAL

Start date2024-03-05

PhaseN/A

Study timeline

Study start (actual)2024-03-05Date precision: day

Registry last updated2025-09-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Interventions

Sponsors & collaborators

Fresenius Kabi SwissBioSim GmbHlead sponsor

Mapped research locations

BerlinGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06247722 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.